Related references
Note: Only part of the references are listed.A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: A secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data
Wendy L. St. Peter et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The calcium acetate renagel evaluation-2 (CARE-2) study
Wajeh Qunibi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
Francesca Tentori et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: Results of a randomized clinical trial
Wadi N. Suki
JOURNAL OF RENAL NUTRITION (2008)
Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis
Takashi Takei et al.
NEPHRON CLINICAL PRACTICE (2008)
Phosphate Binder Impact on Bone Remodeling and Coronary Calcification - Results from the BRiC Study
Daniela Veit Barreto et al.
NEPHRON CLINICAL PRACTICE (2008)
Serum phosphorus and the risk of progression of chronic kidney disease
Csaba P. Kovesdy et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Survival in end stage renal disease: calcium carbonate vs. sevelamer
A. M. Borzecki et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2007)
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
W. N. Suki et al.
KIDNEY INTERNATIONAL (2007)
The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer
D. Russo et al.
KIDNEY INTERNATIONAL (2007)
Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients
Marcello Tonelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients
G. A. Block et al.
KIDNEY INTERNATIONAL (2007)
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients
K. Kalantar-Zadeh et al.
KIDNEY INTERNATIONAL (2006)
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis
GA Block et al.
KIDNEY INTERNATIONAL (2005)
Coronary calcification score: the coronary-risk impact factor
GR Thompson et al.
LANCET (2004)
Using the coronary artery calcium score to predict coronary heart disease events - A systematic review and meta-analysis
MJ Pletcher et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease
G Block et al.
SEMINARS IN DIALYSIS (2003)
Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients:: an open-label, randomized study
T Sadek et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study
AYM Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
GM Chertow et al.
KIDNEY INTERNATIONAL (2002)
Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease
J Blacher et al.
HYPERTENSION (2001)
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
WG Goodman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
